Skystar Bio-Pharmaceutical (OTCBB: SKBI), a leading bio-pharmaceutical company in China, today announced that it has entered into an agreement with TNI-Penta for research and development of new veterinary pharmaceutical products.

Skystar Bio-Pharmaceutical (OTCBB: SKBI), a leading bio-pharmaceutical company in China, today announced that it has signed a letter of intent to initiate a joint scientific research project with Dr. Nicholas P. Plotnikoff, Chairman and CEO of TNI-Penta. Dr.